Several lines of evidence point to leucomyosuppressin (LMS) and myosuppressin-related peptides as inhibitory modulators of heartbeat frequency in arthropods. Previous studies in Blattella germanica demonstrated that heartbeat frequency decreases after ootheca formation, and remains low during the period of ootheca transport. Subsequent work in this cockroach resulted in the characterization of LMS and the cloning and sequencing of its precursor. The present paper describes the activity of LMS on modulation of heartbeat in B. germanica. Assays using semi-isolated heart preparations revealed that LMS reduces heartbeat frequency in a dose dependent manner, at physiological concentrations. Additional experiments showed that LMS inhibits heartbeat rates in vivo. Finally, injection of dsRNA for LMS elicited a decrease in LMS mRNA to virtually undetectable levels and heartbeat frequency increased significantly in females carrying oothecae. These data suggest that LMS contributes to the modulation of cardiac rhythm in B. germanica during the reproductive cycle.
Introduction
Reproduction in cockroaches is characterized by the formation of an egg-case or ootheca, which protects the oviposited eggs. A number of species drop the ootheca immediately after its formation, whereas others, which are evolutionarily more modified, transport it until the emergence of the young (Roth, 1970) . The German cockroach, Blattella germanica, is a good example of this mode of reproduction. It transports the ootheca attached to the genital atrium for a period of ca. 20 days, during which the female produces lower rates of juvenile hormone (Gadot et al., 1989; Maestro et al., 1994) , consumes less food (Lee and Wu, 1994; Osorio et al., 1998) and shows a decreased locomotory activity (Lee and Wu, 1994) . Moreover, heartbeat frequency decreases after ootheca formation, and remains low during the period of ootheca transport (Vilaplana et al., 1999) . Regulatory peptides have been postulated as modulators of cardiac rhythm, and proposed candidates for such a modulation have been YXFGLamide allatostatins, with an inhibitory role, and corazonin with a stimulatory one (Vilaplana et al., 1999) .
However, a number of lines of evidence point to myosuppressin peptides as repressor modulators of heartbeat frequency in insects. Myosuppressins form a subfamily of FMRFamide-related peptides (Orchard et al., 2001) , and the first member to be identified was leucomyosuppressin (LMS), with the structure pQDVDHVFLRFamide, which was isolated from nervous tissues of the cockroach Leucophaea maderae by monitoring its ability to decrease spontaneous hindgut contractions (Holman et al., 1986) . Subsequent heterologous assays showed that LMS inhibits the amplitude and frequency of contractions in semi-isolated heart preparations of the desert locust Schistocerca gregaria (Cuthbert and Evans, 1989) , whereas the endogenous LMS-like peptide of this locust (PDVDHVFLRFamide), also inhibited the spontaneous contractions of the heart (Robb et al., 1989) . In tenebrionid beetles, cockroach LMS significantly decreased the heartbeat frequency in Tenebrio molitor (Wasielewski and Skonieczna, 2008) , whereas the same peptide, isolated from the neuroendocrine system of Zophobas atratus, had a similar effect in this species (Marciniak et al., 2011) . In crustaceans, a neuropeptide with the structure pQDLDHVFLRFamide, thus belonging to the myosuppressin subfamily, has been isolated from a number of species (Ma et al., 2008; Stemmler et al., 2007) . Subsequently, the cDNA corresponding to the peptide precursor has been cloned and sequenced in the American lobster Homarus americanus (Stevens et al., 2009) , where the synthetic peptide decreases heartbeat frequency in vivo and in semi-isolated heart preparations (Stevens et al., 2009 ).
In the cockroach B. germanica, we have isolated and chemically characterized LMS (Aguilar et al., 2004) , and we have also cloned and sequenced the cDNA corresponding to the LMS precursor . However, we have not studied the activity of LMS on modulation of heartbeat in this cockroach. The present contribution aims to establish a possible role of LMS on cardiac rhythm modulation, using RNAi to silence the expression of the peptide precursor.
Materials and methods

Insects
Adult females of B. germanica were obtained from a colony reared with dog chow and water, in the dark at 30 ± 1°C and 60-70% relative humidity. Freshly molted adult females were isolated and used at the appropriate ages. Virgin females were used in the experiments, which were carried out during the first 7 days of the gonadotrophic cycle. To study the period of ootheca transport, mated females were used instead, since they retain the ootheca throughout the entire period of embryogenesis.
Synthetic peptides
Synthetic version of LMS (pQDVDHVFLRFamide), and the analog of ManducaFLRFamide with the C-terminus in acid form (pQDVVHSFLRF-OH), were synthesized in the Proteomics Facility of the Universitat Pompeu Fabra (UPF), using standard Fmoc chemistry, purified to near-homogeneity (>95%) by HPLC and characterized by amino acid analysis and MALDI-TOF mass spectrometry.
Semi-isolated heart preparations
For semi-isolated heart preparations, we used 5-day-old B. germanica females as previously described (Vilaplana et al., 1999) . Briefly, the specimens were pinned ventral side up on a paraffin wax plate and the dorsum with the heart attached was dissected free. The heart preparation was covered with 500 lL of Ringer saline and oxygenated with an air flow above the liquid surface. After 20 min, 150 lL of saline was removed, and the same volume containing the desired concentration of peptide, was added. Heartbeat frequency was recorded every minute for 5 min and then every 5 min for 15 min.
Recording heartbeat rate in vivo
In the experiments of peptide treatments, 1 lL of a MilliQ water peptide solution was injected into the abdomen of CO 2 -anaesthetised 5-day-old adult B. germanica females. Peptide solution was calculated to obtain the desired peptide concentration (10 À6 , 10 À7 or 10 À8 M) in the haemolymph, assuming that a 5-day-old adult B. germanica female has a haemolymph volume of ca. 25 lL (Romaña et al., 1995) Then, the specimen was immobilized dorsal side up on a wax plate, the wings were cut off so the dorsal vessel was visible through the cuticle and the heart beat rate was directly counted. Heartbeat frequency was recorded every min for 5 min. For recording heartbeat frequency in the case of dsRNA-treated animals (see Section 2.6 below), the procedure was similar, although the specimens were not injected with any peptide solution. In these cases we recorded heartbeat rate for each specimen at least three times between minutes 5 and 10.
2.5. Tissue extraction, RNA isolation, cDNA preparation, polymerase chain reaction (PCR), and Southern-blot analysis
Brains and midguts from 5-and 12-day-old females (the later ones carrying the oothecae) were dissected and immediately frozen in liquid nitrogen. RT-PCR followed by Southern blotting was used to estimate mRNA levels. cDNA was synthesized from total RNA as previously described (Maestro and Belles, 2006) . One microgram of total RNA was used for reverse transcription in the case of midguts, whereas in the case of brains, the whole RNA from one brain was used. To estimate mRNA levels semi-quantitatively, a non-saturating number of cycles in the PCR system were used. Primers used for amplifying LMS were: forward, 5 0 -CAGCATCAGAATGAAGTACGT-CAG-3 0 , reverse, 5 0 -AACATTTGTTTACTGTACTGGCCAA-3 0 . As a reference, the same cDNAs were amplified with a primer pair specific for Actin-5C (Maestro et al., 2005) . cDNA probes for Southern blot analyses were generated by PCR with the same primer pairs and labeled with fluorescein, using the Gene Images random prime-labeling module (Amersham Biosciences).
RNA interference
Systemic RNAi in vivo in females of B. germanica was performed as previously described (Maestro and Belles, 2006; Maestro et al., 2009) . A 635-bp fragment spanning positions 95-729 of the BgLMS cDNA was used to generate a dsRNA (dsLMS). As a control, a heterologous sequence of 307 bp from the polyhedrin of Autographa californica nucleopolyhedrovirus (dsMock) was used. A dose of 2 lg was injected into the abdomen of freshly molted adult females. Recording of heartbeat rate in vivo and tissue dissections were performed at the indicated ages.
Results
LMS inhibits heartbeat frequency on semi-isolated heart preparations
To gain an initial insight into the possible role of LMS on B. germanica heart beating, we studied the effect of various concentrations of the synthetic peptide (10 À6 , 10 À7 and 10 À8 M) on semi-isolated heart preparations. As a negative control, we tested pQDVVHSFLRF-OH at 10 À6 M. Results (Fig. 1) show that heartbeat frequency remained more or less constant (around 30 beats/15 s), although tending to increase slightly, during the first 20 min, whereas the administration of LMS produced a fast, dose-dependent and reversible inhibition. The doses of 10 À6 and 10 À7 M elicited 49% and 25% inhibition, respectively. Heartbeat frequency at a dose of 10 À8 M tended to be reduced (by 14%) but did not significantly differ from that measured in the pre-treatment. Treatments with pQDVVHSFLRF-OH did not elicit any apparent response (Fig. 1) .
LMS reduces heartbeat frequency in vivo
The effect of LMS on heartbeat frequency was studied in vivo on 5-day-old adult virgin females. Assuming that the average volume of haemolymph in a female of this age is of ca. 25 lL (Romaña et al., 1995) , we injected the appropriate dose in 1 lL solution to reach final haemolymph peptide concentrations of 10
À6
, 10 À7 and 10 À8 M, just as in the experiments carried out on semi-isolated heart preparations. Also in this case, we used pQDVVHSFLRF-OH at 10 À6 M, as a negative control, and additional control specimens that received only 1 lL water were used. Results (Fig. 2) indicated that the treatment in vivo with LMS also produced a fast, dosedependent and reversible decrease in heartbeat frequency. Differences were most striking 1 min after the treatment, when the dose of 10 À6 M elicited an 86% decrease, whereas that of 10 À7 M gave 55%. Neither the dose of 10 À8 M of LMS, nor that of 10 À6 M of pQDVVHSFLRF-OH elicited significant differences with respect to water controls (Fig. 2) .
RNAi treatment decreases LMS mRNA levels
Freshly molted adult females were treated with dsLMS, maintained without males and killed on day 5 of adult life, to dissect out the brain and the midgut for RT-PCR analysis. A second group was similarly treated, but maintained with males and killed on day 12, during the period of ootheca transport. All the later females formed oothecae correctly around day 7, as is usual in our colony (Aguilar et al., 2003) . Equivalent experiments were carried out with dsMock. Tissues were processed, and results (Fig. 3) showed that LMS mRNA was virtually undetectable in both brain and in midgut tissues in dsLMS-treated specimens on day 5. Expression in dsLMS-treated specimens was still undetectable on day 12. Expression of LMS mRNA was well apparent in dsMock-treated specimens (Fig. 3) .
LMS knockdown increases heartbeat frequency
Using the same experimental design, on day 5 and day 12 of adult life we measured heart beating in adult females that had been treated with dsLMS or dsMock when freshly emerged. Results (Fig. 4) showed that on day 5, heartbeat frequency in dsLMS-treated specimens (37.6 + 0.4 beats/15 s, n = 23) tended to be higher than in the dsMock-treated group (36.8 + 0.4 beats/15 s, n = 22), but differences were not statistically significant (t test, p = 0.0653) (Fig. 4) . On day 12, in animals carrying oothecae, heartbeat frequency in dsLMS-treated specimens (35.2 + 0.4 beats/15 s, n = 25) was significantly higher (t test, p = 0.0153) than in the dsMock-treated specimens (33.5 + 0.5 beats/15 s, n = 24) (Fig. 4) .
Discussion
Experiments on semi-isolated heart preparations showed that LMS reduces heartbeat frequency in a dose dependent manner, with threshold concentrations between 10 À8 and 10 À7 M. These concentrations can be considered physiological for a peptide serving as a circulating hormone. Heterologous assays following this system in vitro with the desert locust, S. gregaria, used concentrations of LMS of 10 À6 M to effectively decrease heartbeat frequency (Cuthbert and Evans, 1989 ). Later, it was shown that the À8 M) and pQDVVHSFLRL-OH (10 À6 M) on heartbeat rate in 5-day-old Blattella germanica semi-isolated heart preparations. The peptides were applied (arrow) after a 20 min stabilization period. Results are expressed as the mean ± SEM (n = 5-7). Asterisks indicate significant differences between values before and after the treatment (Student's t-test: ⁄ P < 0.05; ⁄⁄ P < 0.005). Heartbeat rate was counted every minute for 5 min immediately after peptide injection. Results are expressed as the mean ± SEM (n = 8-13). Asterisks indicate significant differences between peptide and control treatments (Student's t-test: ⁄ P < 0.05; ⁄⁄ P < 0.0005; ⁄⁄⁄ P < 0.0001). . Silencing LMS expression in Blattella germanica females. Specimens were treated immediately after the imaginal molt. LMS mRNA in brain and midgut from dsMock-and dsLMS-treated specimens were analyzed using RT-PCR, followed by Southern-blot. Actin-5C mRNA levels were used as a reference. -RT: negative controls without the reverse transcriptase step.
Actin-5C
LMS
endogenous LMS-like peptide of S. gregaria (PDVDHVFLRFamide) also decreased the spontaneous contractions of the heart at a concentration of 10 À6 M (Robb et al., 1989) . Effective concentrations of LMS used in semi-isolated heart preparations of the tenebrionid beetle T. molitor were between 10 À7 and 10 À6 M (Wasielewski and Skonieczna, 2008) , whereas LMS, identified from brain and retrocerebral complex of Z. atratus, another tenebrionid, inhibited heart contractions of this insect with threshold concentrations of 10 À8 -10 À7 M (Marciniak et al., 2011) . Therefore, the active concentrations found in our experiments using semi-isolated heart preparations with B. germanica are consistent with the results obtained in other insects using similar methods. These concentrations are also similar to those used in heart preparations of the American lobster, H. americanus, and its native LMS-like peptide, pQDLDHVFLRFamide (Stevens et al., 2009) . In this crustacean, concentrations tested to inhibit heart beating were between 10 À9 and 10 À6 M, the effects were dose-dependent, and the threshold concentrations were 10 À8 -10 À7 M (Stevens et al., 2009 ). Our experiments also showed that LMS inhibits heartbeat rates in vivo in B. germanica. This approach in vivo has been used in H. americanus, in which an initial concentration of ca. 10 À7 M in the pericardial cavity significantly decreased the heartbeat frequency (Stevens et al., 2009) , a concentration that is within the range of effective concentrations used in our experiments in vivo. In the case of H. americanus, however, the effects of myosuppressin injections into intact specimens were relatively long-lasting, with a recovery of basal heartbeat frequency taking between 25 min to 1 h. In B. germanica, return to normal frequency took only between 1 and 2 min. This fast recovery suggests that LMS is rapidly degraded by enzymes in the internal milieu of the intact cockroach. Indeed, LMS was shown to be degraded in diluted haemolymph of the moths Spodoptera littoralis and Lacanobia oleracea, with a half-life of 13.1 and 65.4 min, respectively, and degradation was faster in diluted contents of the midgut lumen of the two species (half-life of 0.5 min in L. oleracea, and 2.2 min in S. littoralis) (Matthews et al., 2009) . Degradation of LMS in B. germanica has not been studied, but a study in vivo combining the use of a radioiodinated derivative of the allatostatin DRLYSFGLamide, microdialysis techniques and HPLC analysis with a radioisotope detector, determined that the half-life of this peptide in the internal milieu of the adult female of B. germanica is ca. 4 min (Peralta et al., 2000) .
The RNAi experiments described herein showed that treatment with dsLMS decreases LMS mRNA to virtually undetectable levels, whereas heartbeat frequency increases significantly in females transporting oothecae. Effectiveness of dsRNA treatment for target transcript reduction is not surprising, given that B. germanica has proven to be very sensitive to RNAi in vivo (Belles, 2010) . The derived increase in heartbeat frequency is modest: only a tendency when measured on day 5, during full vitellogenesis, and a modest although statistically significant increase from 33 to 35 beats/ 15 sec, when measured on day 12, during the period of ootheca transport. However, this should be expected in a physiological context if we consider that the cardiac rhythm when the insect forms the ootheca is only reduced about 7-8 beats/15 sec (Fig. 4A) (Vilaplana et al., 1999) . If we hypothesize that such a reduction is regulated by myoinhibitory peptides, then the increase that we can expect when we reduce the expression of such peptides may be within this order of magnitude. The fact that differences between dsLMS-treated and controls on day 5 (during vitellogenesis, previous to ootheca formation) were non-significant, in contrast with the significant differences observed on day 12 (during ootheca carrying), may be due to the different physiological status of these two ages. For example, the lower heartbeat rate measured in ootheca carrying females might be more affected by inhibitory signals (like LMS), thus more prone to show RNAi effects. An additional possibility may be related to differences in peptide decay rates due to differences in the duration of the treatment. In a similar work studying B. germanica preproallatostatin (Maestro and Belles, 2006) , mRNA and peptide levels were analyzed after RNAi, and brain mRNA was reduced close to undetectable levels, whereas brain allatostatin peptide showed 48% and 79% reduction at day 6 and day 14, respectively.
If LMS inhibits heartbeat frequency when the ootheca is formed, then we should expect that LMS expression should be up-regulated at this time. However, LMS mRNA levels in brain tissues of B. germanica are quite constant during the first gonadotrophic cycle and first days of ootheca transport . This suggests that the regulation must be produced at other points, as, for example, in peptide levels, by modulation of the translation of the precursor mRNA, the peptide release or the peptide degradation or at the level of LMS receptor at the heart, among other possibilities. Moreover, the possibility that other peptides contribute to regulation of cardiac rhythm cannot be ruled out. Allatostatins and corazonin are additional obvious candidates to modulate heartbeat frequency in an inhibitory or stimulatory way, respectively (Vilaplana et al., 1999) . However, LMS appears to be a good candidate as a physiological regulator of cardiac rhythm from an evolutionary perspective. Indeed, the fact that myosuppressins have cardioinhibitory properties in insects and crustaceans suggests that modulation of heartbeat frequency might have been an ancestral function of this family of peptides in arthropods. 2010TW0019 (Formosa program) (to X.B.). SST acknowledges the hospitality of the Barcelona team and laboratory, where the experiments were carried out. Asterisk indicates significant differences (Student's t-test: ⁄ P < 0.05).
